The antibacterial activity of acyl derivatives of tylosin were examined in vitro and in vivo.
plasmal activity against some macrolide-resistant strains.
The orally administered 3-acetyl-4"-isovaleryltylosin produced a higher blood level in mice and rabbits than tylosin and a good therapeutic effect on the infection of Staphylococcus aureus Smith in mice.
In a previous paper,1) the preparation of 3-and/or 4"-acyl derivatives of tylosin by microbial transformation and their physico-chemical properties were described. The improved antimicrobial activity of 4"-acylated tylosins against macrolide-resistant clinical isolates of Staphylococcus aureus and Streptococcus pyogenes was briefly reported.2)
Depending on the structure of aglycone, 16-membered macrolide antibiotics can be classified into the carbomycin-leucomycin subgroup and the tylosin-chalcomycin subgroup.
3) It is well known that the substituents at positions 3, 2' and 4" of 16-membered macrolide antibiotics are involved in the degree of the antibacterial activities and the pharmacological properties. For example, OMURA et al. reported that 3-acetylleucomycins were superior to 3-hydroxyleucomycins in the blood level after oral administration, but inferior in the in vitro antibacterial activity; the antibacterial activity of 4"-acylleucomycins was elevated in the increasing order of acetyl, propionyl, butyryl and isovaleryl; 2'-acylated leucomycins were antimicrobially inactive. 3, 4) In the present paper, the antimicrobial activities of acylated tylosins were compared with those of acyl derivatives of angolamycin, spiramycin, leucomycin and carbomycin, with particular reference to the position of acylation. The biological properties of 3-acetyl-4"-isovaleryltylosin which seem most promising from the viewpoints of antimicrobial activity were examined in comparison with those of tylosin.
Materials and Methods

Antibiotics
Tylosin, angolamycin and spiramycin were converted to 3-acetyl-and/or 4"-isovaleryl derivatives by using culture broths or washed mycelia of a high-acylase mutant (strain No. 8254) of Streptomyces thermotolerans ATCC 11416.1) Tylosin was also chemically acylated at the desired position(s) with acetyl chloride and/or isovaleryl chloride after preliminary masking of the other functional (hydroxyl) group(s) with monochloroacetyl chloride. Chemical acylation of tylosin and the microbial acylation of angolamycin and spiramycin will be reported elsewhere.
Leucomycins U and A3, oxytetracycline, erythromycin, chloramphenicol, spiramycin and tylosin were purified from commercially available preparations.
Carbomycin A and angolamycin were prepared by culture of Streptomyces halstedii NRRL B-2331 and Streptomyces erythermus ATCC 14975 respectively. Deltamycin X (4"-deacylcarbomycin A) was prepared by 4"-deacylation of carbomycin A with Bacillus megaterium IAM 1032. 5, 6) Susceptibility tests (1) Antibacterial activity MIC (minimal inhibitory concentrations) were obtained by the two-fold serial agar dilution method in BHIA (brain heart infusion agar) (Eiken Chemical Co., Ltd. Tokyo) supplemented with 10% horse blood for Streptococcus pyogenes and in BHIA for the other test microbes. One loopful of an overnight culture of the test organisms in BHI medium was streaked on assay plates containing the indicated concentration of test materials and the plates were incubated at 37°C for 20 hours. Macrolideresistant clinical isolates of Staphylococcus aureus and Streptococcus pyogenes were supplied by Prof. S. MITSUHASHI, Department of Microbiology, School of Medicine, Gunma University.
(2) Antimycoplasmal activity MIC against Mycoplasma gallisepticum were measured by the serial tube dilution method in the medium containing 17.3 g of dehydrated PPLO enrichment broth (Eiken Chemical Co., Ltd.), 150 ml fresh horse serum (Japan Biotest Co., Ltd., Tokyo), 1,000,000 units potassium benzylpenicillin and 2 mg phenol red (pH 7.8 before autoclaving) per liter.
Serial two-fold dilutions of an antibiotic in the above medium were inoculated with a tenth volume of the seed culture of Mycoplasma (101-108 colony-forming units/ml) and then incubated at 37°C for 3 5 days.
Strains of Mycoplasma gallisepticum employed in the present experiments were supplied by Dr. C. KUNIYASU, National Institute of Animal Health, Kokubunji, Japan. Stability in artificial gastric juice A material was dissolved at a concentration of 1,000 ug/ml in a gastric juice composed of 2.0 g sodium chloride, 3.2 g pepsin and dilute hydrochloric acid in 1,000 ml of distilled water (pH 1.2), and the solution was incubated at 37°C for the indicated periods of time. The antibiotic remaining in the solution was extracted with ethyl acetate at pH 9.0 and then chromatographed on a silicagel thin-layer plate. The amount of the macrolide antibiotic was densitometrically assayed. It was also disc-assayed with Bacillus subtilis ATCC 6633.
Blood levels A single dose of 50, 100 or 200 mg/kg of the drug was orally administered to 5 week-old male ddY mice (20__1 g) (Shizuoka Agricultural Cooperative Association for Experimental Animal, Shizuoka) and 8 month-old male white rabbits (3.0+0.1 kg) (Ichikawaya, Tokyo) which had been fasted overnight.
Mouse blood samples were withdrawn from the retroorbital sinus by heparinised capillary tubes at the indicated times and the tubes were centrifuged at 3,000 xg for 5 minutes to yield plasma. Rabbit blood samples were collected from the auricular vein with a heparinised syringe at the indicated times and centrifuged at 3,000 xg for 5 minutes. Concentrations of the antibiotic in plasma were bioassayed by the paper disk method with Sarcina lutea ATCC 9341.
Therapeutic effect Sixteen hour-old culture of Staphylococcus aureus Smith (pathogen) in heart infusion broth (Eiken Chemical Co., Ltd.) was diluted 5-fold in the same medium and then mixed at 1 : 1 with 10 % hog gastric mucin (Tokyo Chemical Industry Co., Ltd., Tokyo). One half milliliter of the suspension was intraperitoneally injected into 5 week-old ddY mice (male, 20±1 g). A suspension (0.25 ml) of a test antibiotic in 0.5 % sodiumcarboxymethylcellulose (Daiichi Pure Chemical Co., Ltd., Tokyo) was given orally to the experimental groups of 6-10 mice each singly at 1 hour or at the indicated intervals after injection. The survival rate was calculated at 5 days after treatment. and 4"-isovalerylangolamycins (7 and 8) were found to have improved MIC in comparison with the others. The 3-acetyl group seems not to be important for improvement of the antibacterial activity, because 3-acetyltylosin (2) and 3-acetylangolamycin (6) were inactive against these resistant strains as well as tylosin (1) and angolamyein (5).
In contrast, the improvement of the antibacterial activity due to 4"-acylation was not observed in spiramycins, leucomycins and carbomycins all of which belonged to the carbomycin-leucomycin subgroup. It is interesting to note that the 4"-acyl group gives a different effect between tylosin-chalcomycin subgroup and carbomycin-leucomycin subgroup. MIC of the sixteen tylosin derivatives against the sensitive strain and the resistant strain are presented in Table 2 .
Based on the results in Table 2 , the following may be rernarked:
(1) The 3-acetylation neither enhances nor detracts from the antibacterial activity (2 vs. 1 ; 5 vs. 3; 6 vs. 4; 9 vs. 7; 12 vs. 10 in Table 2 ).
(2) The 4"-acylation results in the improved activity against the resistant strain, while no change is caused in the activity against the sensitive strain (4 vs. 1; 6 vs. 2; 13 vs. 2; 9 vs. 5).
(3) The 2'-and/or 4"'-acylations lead to the reduction in the antibacterial activity against the sensitive strain (3 vs. 1 ; 8 vs. 1; 5 vs. 2; 15 vs. 2; 16 vs. 2; 9 vs. 6; 11 vs. 6; 12 vs. 6; 14 vs. 13) and to the elimination of the 4"-acylation dependent effect in the antibacterial activity (7 vs. 4; 10 vs. 4; 9 vs. 6; 11 vs. 6; 12 vs. 6; 14 vs. 13).
In brief, the acylation of 4"-hydroxyl group of tylosin results in the improved antibacterial activity against some macrolide-resistant pathogens, while acylation of the 2'-and/or 4"'-hydroxyl group(s) of tylosin has a negative effect. In contrast to leucomycins, tylosin is not affected in the antibacterial activity by 3-acylation. Among 34 erythromycin-resistant strains of Staphylococcus aureus, 88% were inhibited by less than 50 µg/ml of 3-acetyl-4"-isovaleryltylosin, 94% by 100 µg/ml and 100% by 200 ug/ml, while only 30 % were inhibited by 200 ug/ml of the other macrolides and oxytetracycline. Chloramphenicol was as active as 3-acetyl-4"-isovaleryltylosin (Table 3) . Thus the improvement of antibacterial activity of tylosin against macrolide-resistant Staphylococci due to the 4"-acylation was also shown in the activity against clinical isolates.
Antimycoplasmal Activity Tylosin is currently used for the treatment of mycoplasma infections in animals.
The antimycoplasmal activity of 3-acetyl-4"-isovaleryltylosin and the reference antibiotics was examined against a sensitive strain (KP-13) and the macrolideresistant strains (E-5, E-1 1, A-68 and A-72) of Mycoplasma gallisepticum (Table 4 ).
The effect of 4"-acylation enhanced the antimycoplasmal activity more markedly than the antibacterial activity. Drug was incubated at a concentration of 1,000 ug/ml for the indicated periods of time at 37°C. Amount of the antibiotic remaining was measured by thin-layer chromatography (t.l.c.) and by the disc assay with Bacillus subtilis ATCC 6633.
Stability
in Artificial Gastric Juice
Since most macrolide antibiotics are often administered orally in the treatment of infections, the stability at a pH as low as 1.0 is important. Therefore, the stability of 3-acetyl-4"-isovaleryltylosin in artificial gastric juice (pH 1.2) was examined, testing the activity by bioassay and TLC methods (Table 5) . Tylosin was rapidly decomposed to give desmycosin which was still bioactive.7) Leucomycin A3 and 3-acetyl-4"-isovaleryltylosin, on the other hand, were slowly transformed to demycarosylleucomycin and 3-acetyldesmycosin respectively. Thus, 3-acetyl-4"-isovaleryltylosin was shown to be more stable in the stomach than tylosin. 3-acetyltylosin or 3-acetyl-4"-isovaleryltylosin was orally given to mice and rabbits, the blood samples Table 6 . Blood levels of 3-acetyl-4"-isovaleryltylosin after oral administration into mice and rabbits. were collected at the indicated times and the concentrations of the antibiotics were bioassayed with Sarcina lutea ATCC 9341 (Table 6 ).
In mice, 3-acetyl-4"-isovaleryltylosin provided a markedly higher level than tylosin and 3-acetyltylosin. This was more clearly confirmed in rabbits. Since 3-acetyltylosin was as poor as tylosin, the improved blood level with 3-acetyl-4"-isovaleryltylosin could be ascribed to 4"-isovalerylation.
Treatment of Experimental Infections with
Staphylococcus aureus Smith
Therapeutic effect of orally given 3-acetyl-4"-isovaleryltylosin was examined on mice systemically infected with Staphylococcus aureus Smith ( Table 7) . It is apparent that 3-acetyl-4"-isovaleryltylosin is superior to tylosin in the in vivo effect. This agrees with the improved blood levels. Multiple doses of 3-acetyl-4"-isovaleryltylosin showed a good effect in preventing the infection.
